Sera Prognostics
Sera Prognostics, based in Salt Lake City, Utah, develops and offers the PreTRM Test, a predictive blood test for the risk of spontaneous preterm delivery in singleton pregnancies.
About Sera Prognostics
Sera Prognostics specializes in maternal and neonatal health, offering advanced pregnancy biomarker information through innovative tests. The company is headquartered in Salt Lake City, Utah, and operates a CLIA certified, CAP accredited, and New York State approved laboratory. Sera Prognostics focuses on the development of blood-based biomarker tests designed to address various pregnancy-related health concerns.
PreTRM Test
The PreTRM Test by Sera Prognostics is a blood test designed to predict the risk of spontaneous preterm delivery in asymptomatic singleton pregnancies. This test identifies higher-risk pregnancies even when there are no evident risk factors, allowing healthcare providers to intervene early. The test uses the IBP4/SHBG biomarkers and has published data confirming its performance in diverse non-U.S. populations.
Research and Development
Sera Prognostics is actively engaged in the research and development of novel blood-based biomarker tests to address pregnancy-related concerns. The primary focus is on improving health outcomes for both mothers and babies through early risk detection and intervention strategies. Their efforts include health economic analysis to support the cost-effectiveness of these innovative tests.
Laboratory Certifications and Accreditations
Sera Prognostics operates a laboratory that holds multiple certifications and accreditations. The lab is CLIA certified, CAP accredited, and approved by New York State. These credentials ensure that the laboratory meets high standards of quality and reliability in its testing processes.
Health Economic Benefits
Sera Prognostics provides a test-and-treat strategy with the PreTRM Test to assess and manage the risk of preterm labor. This approach aims to improve health outcomes for mothers and infants while also reducing overall healthcare costs. Health economic analyses conducted by the company support the cost-effectiveness of their testing solutions.